Search alternatives:
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
Showing 15,341 - 15,360 results of 64,555 for search '(( 5 ((026 decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 5 point decrease ))', query time: 0.93s Refine Results
  1. 15341
    Table_1_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX

    Table_1_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
    Save to List
    Saved in:
  2. 15342
    Image_6_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.JPEG

    Image_6_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.JPEG by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
    Save to List
    Saved in:
  3. 15343
    Table_4_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX

    Table_4_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
    Save to List
    Saved in:
  4. 15344
    Table_7_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX

    Table_7_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
    Save to List
    Saved in:
  5. 15345
    Pseudotime trajectory and TCR clonal type analyses reveal CD4 T cell differentiation and clonal expansion profiles in WT and <i>Bhlhe40</i><sup><i>-/-</i></sup> mice.

    Pseudotime trajectory and TCR clonal type analyses reveal CD4 T cell differentiation and clonal expansion profiles in WT and <i>Bhlhe40</i><sup><i>-/-</i></sup> mice. by Miguel A. B. Mercado (17847533)

    Published 2024
    Save to List
    Saved in:
  6. 15346
    Down-regulation of VANGL2 in IBD patients triggers overt activation of NLRP3 inflammasome.

    Down-regulation of VANGL2 in IBD patients triggers overt activation of NLRP3 inflammasome. by Huaji Jiang (16907514)

    Published 2025
    Save to List
    Saved in:
  7. 15347
    Healthcare workers follow-up, 6 months after vaccination.

    Healthcare workers follow-up, 6 months after vaccination. by Angélica Ramos (3124074)

    Published 2024
    Save to List
    Saved in:
  8. 15348
    Summary of differences in game-related performance parameters between (a) regular and post-season competitive periods, (b) winning and losing game outcomes during the regular season competitive period, and (c) winning and losing outcomes during the post-season competitive period.

    Summary of differences in game-related performance parameters between (a) regular and post-season competitive periods, (b) winning and losing game outcomes during the regular seaso... by Dimitrije Cabarkapa (13272186)

    Published 2022
    Save to List
    Saved in:
  9. 15349
    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  10. 15350
    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  11. 15351
    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  12. 15352
    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  13. 15353
    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  14. 15354
    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  15. 15355
    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  16. 15356
    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  17. 15357
    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif

    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…<p>Ubiquitin-specific protease 5 (USP5) is a deubiquitinating enzyme that functions as an oncoprotein in a variety of human cancers. …”
    Save to List
    Saved in:
  18. 15358
    Image_4_WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.jpeg

    Image_4_WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.jpeg by Sarah J. Hartman (9602994)

    Published 2021
    “…Cell cycle distribution was disrupted from the combination of AZD1775 with SN38 or 5-FU which was recorded as G2M arrest and decreased G1 phase. …”
    Save to List
    Saved in:
  19. 15359
    Image_3_WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.jpeg

    Image_3_WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.jpeg by Sarah J. Hartman (9602994)

    Published 2021
    “…Cell cycle distribution was disrupted from the combination of AZD1775 with SN38 or 5-FU which was recorded as G2M arrest and decreased G1 phase. …”
    Save to List
    Saved in:
  20. 15360
    Image_1_WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.jpg

    Image_1_WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.jpg by Sarah J. Hartman (9602994)

    Published 2021
    “…Cell cycle distribution was disrupted from the combination of AZD1775 with SN38 or 5-FU which was recorded as G2M arrest and decreased G1 phase. …”
    Save to List
    Saved in:

Search Tools: